In this case, SON-1010 bound to albumin is pulled through the endothelial cells into the TME and is retained in that space by extracellular SPARC, giving the IL-12 extended time to activate the local immune response for better tumor control (Figure 1). The gene discussed is ALB; the disease is neoplasm.